Cromolyn sodium salt, 98%
Cromolyn sodium salt, 98%
Cromolyn sodium salt, 98%
Thermo Scientific Chemicals

Cromolyn sodium salt, 98%

Mast cell stabilizer that prevents release of histamine from mast cells | CAS: 15826-37-6 | C23H14Na2O11 | 512.33 g/mol
製品番号(カタログ番号) J65122.03
または、製品番号J65122-03
価格(JPY)
-
数量:
1 g
一括またはカスタム形式をリクエストする
化学物質識別子
CAS15826-37-6
IUPAC Namedisodium 5-{3-[(2-carboxylato-4-oxo-4H-chromen-5-yl)oxy]-2-hydroxypropoxy}-4-oxo-4H-chromene-2-carboxylate
Molecular FormulaC23H14Na2O11
InChI KeyVLARUOGDXDTHEH-UHFFFAOYSA-L
SMILES[Na+].[Na+].OC(COC1=C2C(=O)C=C(OC2=CC=C1)C([O-])=O)COC1=C2C(=O)C=C(OC2=CC=C1)C([O-])=O
さらに表示
Appearance (Color)White to pale yellow
FormPowder
Purity≥97.5%
Cromolyn sodium salt is used as a mast cell stabilizer that prevents release of histamine and other pro-inflammatory mediators from mast cells. Cromolyn sodium salt is used as a chemopreventive and an anti-inflammatory agent.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Cromolyn sodium salt is used as a mast cell stabilizer that prevents release of histamine and other pro-inflammatory mediators from mast cells. Cromolyn sodium salt is used as a chemopreventive and an anti-inflammatory agent.

Solubility
Soluble in water to 100mg/ml

Notes
Store away from strong oxidizing agents. Keep container tightly closed. Store in cool, dry conditions in well sealed containers.
RUO – Research Use Only

General References:

  1. Felice Nava.; Achille P. Caputi. Central effects of cromoglycate sodium salt in rats treated with lipopolysaccharide. European Journal of Pharmacology. 1999, 367, (2-3), 351-359.
  2. Elisabetta Esposito.; Enea Menegatti.; Rita Cortesi. Hyaluronan-based microspheres as tools for drug delivery: a comparative study. International Journal of Pharmaceutics. 2005, 288, (1), 35-49.